A resolution about cannabis for medicinal purposes was approved by the European Parliament on 13th of February, aiming to promote the research and the availability of medical cannabis-based products. Just as the Recommendations of the WHO to reschedule cannabis and cannabis products, the European institutions are promoting the so-called medicalisation of cannabis, which means that they are trying to standardize both the term “cannabis as medicine” and the substances that will be available. However, they seem to have forgotten the plant’s flowers as a complete and useful medicine on its own, giving preference to big pharma.
We thank the left-wing coalitions, such as European United Left-Nordic Green Left (GUE-NGL) and Greens–European Free Alliance (Greens–EFA) for introducing a more social approach and for trying to make a more comprehensive and inclusive resolution. Despite their efforts, the resolution constantly refers to the medicalization of cannabis-based products by using pharmaceutical formulas, extracting cannabinoids from the plant and synthesizing others, which is just not necessary for a plant that already has several compounds that have therapeutic effects.
Read the whole document:
INSIGHT EUROPEAN PARLIAMENT RESOLUTION ON CANNABIS FOR MEDICINAL PURPOSES